Show simple item record

dc.contributor.authorDaar, AS
dc.contributor.authorBerndtson, K
dc.contributor.authorPersad, DL
dc.contributor.authorSinger, PA
dc.date.accessioned2020-12-21T02:10:32Z
dc.date.available2020-12-21T02:10:32Z
dc.date.issued2007-12-03
dc.identifierpii: 1471-2458-7-346
dc.identifier.citationDaar, A. S., Berndtson, K., Persad, D. L. & Singer, P. A. (2007). How can developing countries harness biotechnology to improve health?. BMC PUBLIC HEALTH, 7 (1), https://doi.org/10.1186/1471-2458-7-346.
dc.identifier.issn1471-2458
dc.identifier.urihttp://hdl.handle.net/11343/256813
dc.description.abstractBACKGROUND: The benefits of genomics and biotechnology are concentrated primarily in the industrialized world, while their potential to combat neglected diseases in the developing world has been largely untapped. Without building developing world biotechnology capacity to address local health needs, this disparity will only intensify. To assess the potential of genomics to address health needs in the developing world, the McLaughlin-Rotman Centre for Global Health, along with local partners, organized five courses on Genomics and Public Health Policy in the developing world. The overall objective of the courses was to collectively explore how to best harness genomics to improve health in each region. This article presents and analyzes the recommendations from all five courses. DISCUSSION: In this paper we analyze recommendations from 232 developing world experts from 58 countries who sought to answer how best to harness biotechnology to improve health in their regions. We divide their recommendations into four categories: science; finance; ethics, society and culture; and politics. SUMMARY: The Courses' recommendations can be summarized across the four categories listed above: SCIENCE: - Collaborate through national, regional, and international networks- Survey and build capacity based on proven models through education, training, and needs assessments FINANCE: - Develop regulatory and intellectual property frameworks for commercialization of biotechnology- Enhance funding and affordability of biotechnology- Improve the academic-industry interface and the role of small and medium enterprise ETHICS, SOCIETY, CULTURE: - Develop public engagement strategies to inform and educate the public about developments in genomics and biotechnology- Develop capacity to address ethical, social and cultural issues- Improve accessibility and equity POLITICS: - Strengthen understanding, leadership and support at the political level for biotechnology- Develop policies outlining national biotechnology strategyThese recommendations provide guidance for all those interested in supporting science, technology, and innovation to improve health in the developing world. Applying these recommendations broadly across sectors and regions will empower developing countries themselves to harness the benefits of biotechnology and genomics for billions who have long been excluded.
dc.languageEnglish
dc.publisherBIOMED CENTRAL LTD
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.titleHow can developing countries harness biotechnology to improve health?
dc.typeJournal Article
dc.identifier.doi10.1186/1471-2458-7-346
melbourne.affiliation.departmentSchool of Historical and Philosophical Studies
melbourne.source.titleBMC Public Health
melbourne.source.volume7
melbourne.source.issue1
dc.rights.licenseCC BY
melbourne.elementsid1232334
melbourne.contributor.authorSinger, Peter
dc.identifier.eissn1471-2458
melbourne.accessrightsOpen Access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record